B
13.15
-2.07 (-13.60%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 看跌 | 混合的 |
| Medical Devices (全球的) | 看跌 | 混合的 | |
| 股票 | Beta Bionics, Inc. | - | - |
AIStockmoo 评分
0.4
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.0 |
| 平均 | 0.38 |
|
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product include the iLet Bionic Pancreas (iLet). The Company operates as single segment, focused on the development, manufacture and sale of the iLet. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 内部持股比例 | 7.52% |
| 机构持股比例 | 57.74% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 31.00 (Ladenburg Thalmann, 135.74%) | 购买 |
| 中 | 27.00 (105.32%) | |
| 低 | 20.00 (Baird, 52.09%) | 保留 |
| 平均值 | 26.67 (102.81%) | |
| 总计 | 5 购买, 1 保留 | |
| 平均价格@调整类型 | 20.69 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Lake Street | 24 Feb 2025 | 30.00 (128.14%) | 购买 | 20.60 |
| Leerink Partners | 24 Feb 2025 | 28.00 (112.93%) | 购买 | 20.60 |
| Piper Sandler | 24 Feb 2025 | 26.00 (97.72%) | 购买 | 20.60 |
| Stifel | 24 Feb 2025 | 25.00 (90.11%) | 购买 | 20.60 |
| Baird | 20 Feb 2025 | 20.00 (52.09%) | 保留 | 20.87 |
| Ladenburg Thalmann | 20 Feb 2025 | 31.00 (135.74%) | 购买 | 20.87 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合